Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
AN2 Therapeutics, Inc. ( (ANTX) ) has shared an announcement.
AN2 Therapeutics has promoted its Chief Legal Counsel, Joshua Eizen, to the roles of Chief Legal Officer and Chief Operating Officer, effective immediately. Eizen’s new compensation package includes a salary of $450,000, stock options, and restricted stock units that vest over time. This move is part of AN2’s strategic efforts to strengthen its leadership team, appealing to investors looking at executive management changes.
See more data about ANTX stock on TipRanks’ Stock Analysis page.
